WeChat Mini Program
Old Version Features

First-line Osimertinib for Patients with EGFR-mutated Advanced Non-Small Cell Lung Cancer: Efficacy and Safety During the COVID-19 Pandemic.

Suganija Lakkunarajah,Pauline T. Truong,Jeffrey N. Bone,Curtis Hughesman,Stephen Yip,Deepu Alex,Jason Hart,Philip Pollock,Sarah Egli,Melissa Clarkson,Mary Lesperance,Doran Ksienski

TRANSLATIONAL LUNG CANCER RESEARCH（2023）

Cited 1|Views22
Key words
Osimertinib,lung cancer,epidermal growth factor receptor (EGFR),survival,COVID-19
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined